Why Oral GLP-1 Drugs Could Change Diabetes Care
GLP-1 medications are currently the talk of the town. If you live with type 2 diabetes, you've probably heard a lot about these and…
Do you have Type 2 Diabetes and use (or are willing to start) basal insulin? You may qualify for a research study evaluating a new glucose monitoring system.
This study is designed to evaluate how an FDA-cleared CGM system and basal insulin dose calculator work, and to confirm it is safe to use. Participants will wear the study CGM device and use a mobile app that provides daily insulin dose recommendations for approximately 4 months. Weekly telephone check-ins are also included.
To take part in the study, participants should:
CEO and Medical Director
Director of Clinical Research
Clinical Research Coordinator
Navigator/Study Start-up Manager
Clinical Research Coordinator
Clinical Research Coordinator